Table 1.

Socio-demographic and clinical characteristics of eligible colorectal cancer survivors included and not included in the current analyses

Characteristic	Included in analyses (n = 145)		Not included in analyses (n = 228)		p a
	n	%	n	%
Age (years)					<.01
Mean	70.0		73.4
SD	8.7		11.8
Years since diagnosis					.97
Mean	5.7		5.7
SD	1.9		1.6
Gender					.35
Men	91	62.8	132	57.9
Women	54	37.2	96	42.1
Tumor subsite					.46
Colon	78	53.8	137	60.1
Rectosigmoid	7	4.8	8	3.5
Rectum	60	41.4	83	36.4
Cancer stageb					.84
I	40	29.2	58	26.4
II	50	36.5	85	38.6
III	47	34.3	77	35.0
Treatment with surgery					.55
Yes	139	95.9	222	97.4
No	6	4.1	6	2.6
Treatment with chemotherapy					.14
Yes	75	51.7	100	43.9
No	70	48.3	128	56.1
Treatment with radiotherapy					.18
Yes	55	37.9	71	31.1
No	90	62.1	157	68.9
Number of comorbid conditions
None	35	24.1
1	36	24.8
≥2	74	51.0
Stoma (colostomy/ileostomy)
Yes	24	16.6
No	121	83.4
Body mass index (kg/m2)
Mean	27.6
SD	4.3
Education level
Low	37	25.5
Medium	48	33.1
High	60	41.4
Smoking status
Current	16	11.0
Former	98	67.6
Never	31	21.4
Perceived deficiency in social supportc
Yes	64	44.4
No	80	55.6
Paid employment
Yes	24	16.6
No	121	83.4

SD standard deviation

^aTesting differences in characteristics between included and not included eligible colorectal cancer survivors if data were available for both groups; by Pearson’s Chi-square test for most categorical variables (gender, tumor subsite, tumor stage, and treatment with radiotherapy and chemotherapy), Fisher’s exact test for treatment with surgery (due to expected frequency below 5 in one cell), and independent t test for continuous variables (age and years since diagnosis)

^bData missing for 16 cases (eight included and eight excluded survivors)

^cData missing for one participant; dichotomized based on six-item Social Support List score (scale: 6–18, with higher score indicating higher deficiency); categorized into no deficiency (score = 6) vs deficiency (score > 6)